Genexine ranked among the top searched stocks for 12 days in the past month.


As of 11:30 AM on the 15th, Genexine is trading at 113,800 KRW, down 7.33% from the previous day. This represents a 25.52% decline compared to December 7. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners have sold a net 9,000 shares of Genexine, and institutions have sold a net 16,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 139,597 shares, while foreigners and institutions have sold a net 31,433 shares and 98,553 shares, respectively.


On December 14, Genexine was a market topic with the headline "Strong performance as the largest shareholder of ToolGen."





[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing